Menu
1 min read · estimated
APPROVED USE
What FDA approved
For adults and children age 12 years or older with pheochromocytoma or paraganglioma that is locally advanced, unresectable, or metastatic.
LAMPGEN ANALYSIS
Why it matters
This label expansion introduced an oral HIF-2α inhibitor to a rare neuroendocrine tumor population.
What research teams should watch
Design referral from endocrinology and oncology and build anemia and oxygenation checks into visit schedules.
PRIMARY RECORDS